Bajrang Dal activist thrashed by public for harassing woman

Mangaluru, Jan 7: Kasturba Medical College Mangaluru, a constituent unit of Manipal Academy of Higher Education (MAHE), in association with Pai Family Endowment (in memory of Shri Suhas Gopal Pai) as its social initiative opens a newborn hearing assessment centre at Govt Lady Goshen Hospital on Tuesday.

Dr M Venkatraya Prabhu, Dean of KMC Mangaluru addressing the media persons said that the project is made possible by the generous philanthropic contribution of Mrs Anuradha (Shanthi)Gopal Pai and will be inaugurated by her in Presence of Dr H Vinod Bhat, Vice-Chancellor of MAHE.

Dr Deepak Madi, Deputy Medical Superintendent KMC Hospital Attavar explained that the facility will be managed by the departments from Audiology, ENT and Paediatrics of Kasturba Medical College, Mangaluru. The Centre aims to screen all the babies born in the hospital for hearing loss.

This is the maiden initiative of the MAHE-Pai Family endowment which has been set up to find solutions for the numerous challenges faced by the hearing handicapped in & around Dakshina Kannada district.

Bengaluru, Mar 30: The total number of COVID-19 cases in Karnataka has climbed to 88 on Sunday after five more persons tested positive for the lethal infection.

"Five more COVID-19 cases reported in Karnataka taking positive cases in the state to 88," said the State health department.

Of the five, one is a close contact of an earlier confirmed patient and the others are workers of a pharmaceutical company in Mysuru, from where a person had tested positive, the department said.

The country is under a 21-day lockdown to prevent the spread of coronavirus, which according to the Ministry of Health and Family Welfare, has infected 1,071 people so far.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.